rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2004-10-7
|
pubmed:abstractText |
The effect of p53 protein expression and MIB-1 proliferative activity on survival and chemotherapeutic response in patients with lymph node (LN)-positive transitional cell carcinoma (TCC) of the urinary bladder remains unclear. The objective of this study was to assess the ability of these markers to predict disease-associated outcomes and response to chemotherapy in a cohort of patients with LN-positive TCC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1803-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15386300-Carcinoma, Transitional Cell,
pubmed-meshheading:15386300-Chemotherapy, Adjuvant,
pubmed-meshheading:15386300-Cohort Studies,
pubmed-meshheading:15386300-Cystectomy,
pubmed-meshheading:15386300-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15386300-Humans,
pubmed-meshheading:15386300-Ki-67 Antigen,
pubmed-meshheading:15386300-Lymph Nodes,
pubmed-meshheading:15386300-Lymphatic Metastasis,
pubmed-meshheading:15386300-Neoplasm Recurrence, Local,
pubmed-meshheading:15386300-Neoplasm Staging,
pubmed-meshheading:15386300-Prognosis,
pubmed-meshheading:15386300-Treatment Outcome,
pubmed-meshheading:15386300-Tumor Markers, Biological,
pubmed-meshheading:15386300-Tumor Suppressor Protein p53,
pubmed-meshheading:15386300-Urinary Bladder Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
|
pubmed:affiliation |
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA. frank.igor@mayo.edu
|
pubmed:publicationType |
Journal Article
|